Organization

Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria

2 abstracts

Abstract
AN UPDATE ON THE INTEGRATED SAFETY ANALYSIS OF FILGOTINIB IN PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS OVER A MEDIAN OF 4.3 YEARS
Org: Oregon Health and Science University, School of Medicine, Portland, United States of America, Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria, University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy, ASST Gaetano Pini-CTO, Department of Rheumatology and Medical Sciences, Milan, Italy, University of Occupational and Environmental Health, Department of Internal Medicine, Kitakyushu, Japan,
Abstract
Arp2/3 AS A Lasp1 INTERACTION PARTNER REGULATES CELL-TO-CELL CONTACT FORMATION OF FIBROBLAST-LIKE SYNOVIOCYTES IN RA
Org: University Hospital Muenster, Institute of Musculoskeletal Medicine, Muenster, Germany, Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria, University Hospital of Muenster, Department of Nephrology and Rheumatology, Internal Medicine D, Muenster, Germany,